Companies › SILO

SILO PHARMA INC (SILO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001514183 · EDGAR filings · Updated 2026-07-24

SILO PHARMA INC (SILO) has reported institutional ownership of 7.5%, with 15 institutional managers holding positions valued at $379.8K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — Shelf registration (S-3) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-14 — D filed
• 2026-07-13 — Current report (8-K) filed
• 2026-07-08 — SCHEDULE 13G filed
• 2026-06-30 — ARS filed
• 2026-06-30 — DEFA14A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SILO PHARMA INC has 15 institutional holders and institutional ownership of 7.5%.

Insider activity

Insiders reported 7 transactions (7 buys, 0 sells) across 1 reporting insiders, with a net reported value of $12.0K.

Data flags from SEC filings

Related companies

Lunai Bioworks Inc (LNAI) · PMGC HLDGS INC (ELAB) · Theriva Biologics Inc (TOVX) · NEXALIN TECHNOLOGY INC (NXL) · MUSTANG BIO INC (MBIO) · ACLARION INC (ACON)